Abstract
Background: Many studies have confirmed headache as one of the most common COVID-19-related neurological symptoms. There are some reports concerning migraine attacks during SARS-CoV-2 infection with an unusual course of migraine attack. Our aim was to recognize and characterize accurately the features of headaches accompanying this disease. Methods: Research based on questionnaire study gathered 100 randomly chosen medical healthcare employees who experienced symptoms associated with COVID-19 disease, 96 with confirmed COVID-19 (positive SARS-CoV-2 PCR laboratory test or positive rapid COVID-19 antigen test). Conclusion: Headaches reported in the study did not fulfill criteria for migraine with/without aura, tension-type headache according to ICHD-3.
Highlights
The first cases of unknown severe pneumonia were observed in Wuhan, the capital of Hubei Province, China, in December 2019
Many neurological manifestations have been reported in the literature associated with COVID-19, which we can classify into central nervous system (CNS)-related manifestations including headache, dizziness, impaired consciousness, acute cerebrovascular disease, and epilepsy, or peripheral nervous system (PNS) related manifestations such as hyposmia/anosmia, hypogeusia/ageusia, muscle pain, and Guillain–Barre syndrome [4]
We found that migraine visual aura preceding headache was noticed in 6/83 (7%) patients, unilateral headache character occurred in 6%, and the pulsating headache type without unilateral character was in 17% of participants
Summary
The first cases of unknown severe pneumonia were observed in Wuhan, the capital of Hubei Province, China, in December 2019. It has been proven indubitably that coronaviruses possess neurotropic and neuroinvasive properties in various hosts including humans, rats, pigs, rodents and fowl [2]. Many neurological manifestations have been reported in the literature associated with COVID-19, which we can classify into central nervous system (CNS)-related manifestations including headache, dizziness, impaired consciousness, acute cerebrovascular disease, and epilepsy, or peripheral nervous system (PNS) related manifestations such as hyposmia/anosmia, hypogeusia/ageusia, muscle pain, and Guillain–Barre syndrome [4]. Many studies have confirmed headache as one of the most common COVID19-related neurological symptoms. Methods: Research based on questionnaire study gathered 100 randomly chosen medical healthcare employees who experienced symptoms associated with COVID-19 disease, 96 with confirmed COVID-19 (positive SARS-CoV-2 PCR laboratory test or positive rapid COVID-19 antigen test). Conclusion: Headaches reported in the study did not fulfill criteria for migraine with/without aura, tension-type headache according to ICHD-3.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
